Fig. 5

Site specific differences of cumulative dose of glucocorticoid given (a) and the length of treatment (b) at first presentation. Further illustrated are the site-specific differences of cumulative dose of glucocorticoid given (c) and length of treatment (d) at relapse. Data from 2 sites were not shown due to low enrollment at the time of this report. Note: ^I Sites 1, 3,5,6,7,9,10 used protocol based treatments for nephrotic syndrome while Sites 2, 4, 8 did not. ^II Number of patients for sites 1–10 in first presentation graphs were 45, 3, 2, 37, 8, 29, 30, 22, 36 and 29 respectively. ^III Number of patients for sites 1–10 in relapse graphs were 32, 2, 1, 22, 6, 20, 22, 17, 24 and 18 respectively